Combined Blockade of Src Kinase and Epidermal Growth Factor Receptor with Gemcitabine Overcomes STAT3-Mediated Resistance of Inhibition of Pancreatic Tumor Growth

類似資料

• Targeted inhibition of Src kinase signaling attenuates pancreatic tumorigenesis
  著者:: Nagaraj, Nagathihalli S., 等
  出版事項: (2010)
• Combined Src/EGFR inhibition targets STAT3 signaling and induces stromal remodeling to improve survival in pancreatic cancer
  著者:: Dosch, Austin R., 等
  出版事項: (2020)
• Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells
  著者:: Dosch, Austin R., 等
  出版事項: (2019)
• Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth
  著者:: Messaggio, Fanuel, 等
  出版事項: (2017)
• Dual Src and EGFR Inhibition in Combination with Gemcitabine in Advanced Pancreatic Cancer: Phase I Results
  著者:: Cardin, Dana B., 等
  出版事項: (2017)